Rapport Therapeutics Inc.... (RAPP)
NASDAQ: RAPP
· Real-Time Price · USD
26.19
1.46 (5.90%)
At close: Sep 16, 2025, 3:59 PM
26.16
-0.11%
After-hours: Sep 16, 2025, 07:54 PM EDT
5.90% (1D)
| Bid | 26.17 |
| Market Cap | 955.88M |
| Revenue (ttm) | 720K |
| Net Income (ttm) | -88.31M |
| EPS (ttm) | 1.2 |
| PE Ratio (ttm) | 21.83 |
| Forward PE | -6.2 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 26.19 |
| Volume | 1,341,160 |
| Avg. Volume (20D) | 589,924 |
| Open | 25.74 |
| Previous Close | 24.73 |
| Day's Range | 24.43 - 26.50 |
| 52-Week Range | 6.43 - 42.27 |
| Beta | 0.75 |
| Ex-Dividend Date | n/a |
About RAPP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RAPP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RAPP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
-20.09%
Rapport Therapeutics shares are trading lower afte...
Unlock content with
Pro Subscription
1 week ago
-10.93%
Rapport Therapeutics shares are trading lower after the company announced a $250 million public offering.
